期刊文献+

全面质量管理在胃肠肿瘤患者围手术期护理中的临床效果 被引量:5

Clinical effect of comprehensive quality management in perioperative nursing of patients with gastrointestinal tumor
在线阅读 下载PDF
导出
摘要 目的探讨全面质量管理应用于胃肠肿瘤患者围手术期护理中的临床效果。方法选取我院2015年10月至2016年5月治疗的胃肠肿瘤患者80例,随机分为对照组与研究组,各40例。对照组患者围术期给予常规质量管理,研究组患者围术期应用全面质量管理。比较两组患者的临床效果。结果研究组患者健康知识知晓率明显高于对照组(P<0.05);研究组患者护理安全事件发生率明显低于对照组(P<0.05);研究组患者护理质量评分明显高于对照组(P<0.05);研究组患者的护理满意度明显高于对照组(P<0.05)。结论胃肠肿瘤患者围术期护理中应用全面质量管理能够明显提高患者对疾病的认知水平,降低护理安全事件的发生率,提高护理质量评分,值得临床推广应用。 Objective To investigate the clinical effect of comprehensive quality management in perioperative nursing of patients with gastrointestinal tumor. Methods Eighty cases of patients with gastrointestinal tumor admitted in our hospital from October 2015 to May 2016 were selected and randomly divided into control group and study group, with 40 cases in each group. The control group was treated with routine quality management in the perioperative nursing, and the study group was given comprehensive quality management in the perioperative nursing. The clinical effects of the two groups were compared. Results The awareness rate of health knowledge in study group was significantly higher than that in control group (P〈0.05). Compared with the control group, in the study group the security incident rate in nursing was lower, the nursing quality scores were higher, and the nursing satisfaction rate was higher (P〈0.05). Conclusion Comprehensive quality management in perioperative nursing of patients with gastrointestinal tumor can improve the patients' disease cognition, reduce the occurrence of security incidents rate in nursing, and improve the quality scores. It is worthy of application in clinic.
出处 《临床医学研究与实践》 2017年第28期142-143,共2页 Clinical Research and Practice
关键词 全面质量管理 胃肠肿瘤 围术期护理 comprehensive quality management gastrointestinal tumor perioperative nursing
作者简介 吴秀婷(1978-),女,汉族,陕西南郑人,主管护师,学士。研究方向:手术室护理配合。 通讯作者:贺彩玲,E-mail:1257567458@qq.com.
  • 相关文献

参考文献4

二级参考文献44

  • 1Baselga J. The EGFR as a target for anticancer therapy--focus on ce- tuximab[J]. Eur J Cancer,2001,37(suppl 4):S16-22.
  • 2Therasse P,Arbuck SG,Eisenhauer EA,et al. New guidelines to evalu- ate the response to treatment in solid tumors:European organization for research and treatment of cancer,national cancer institute of the united states,national cancer institute of canada[J]. J Natl Cancer Inst,2000, 92(3) :205-216.
  • 3Trotti A,Colevas AD,Setser A,et al. Development of a comprehensive grading system for the adverse effects of cancer treatment[J]. Semin Radiat Oncol,2003,13(3) : 176-181.
  • 4David K Cetuximab in metastatic colorectal cancer[J]. London Cancer New Drugs Group,2005,7(1 ) : 1-10.
  • 5Cunningham D,Humblet Y,Siena S,et al. Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer[J]. N Engl J Med,200d,351 (g):337-345.
  • 6Huang S,Bock J,Harari P,et al. Epidermal growth factor receptor blockade with C225 modulates proliferation,apoptosis,and radiosensitivi- ty in squamous cell carcinomas of the head and neck[J]. Cancer Res, 1999,59 ( 11 ) : 1935-1940.
  • 7Saltz L,Cox J,Blanke C,et al. Irinotecan plus fluorouracil and leucovorin for metastatic colorectsl cancer[J]. N Engl J Med,2000,343(13):905-914.
  • 8Harding J,Burtness B. Cetuximab:an epidermal growth factor receptor chimeric human-murine monoclonal antibody[J]. Drugs Today,2005,41 (2) : 107-127.
  • 9吕云,祝学敏,赵建华.癌症病人的心理状态及护理体会[J].河南外科学杂志,2010,16(2):128.
  • 10Yifat Edrei,Moti Freiman,Miri Sklair‐Levy,Galia Tsarfaty,Eitan Gross,Leo Joskowicz,Rinat Abramovitch.Quantitative functional MRI biomarkers improved early detection of colorectal liver metastases[J]. J. Magn. Reson. Imaging . 2014 (5)

共引文献30

同被引文献39

引证文献5

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部